Less Ads, More Data, More Tools Register for FREE

Pin to quick pickseEnergy Group Regulatory News (EAAS)

Share Price Information for eEnergy Group (EAAS)

Share Price is delayed by 15 minutes
Get Live Data
5.05    0.00 (0.00%)
Bid:
4.80
Ask:
5.30
Spread: 0.50 (10.417%)
Market Cap: £19.55m
EAAS Live PriceLast checked at - London Stock Exchange

Intraday eEnergy Group Share Chart

Research and Development Update

25 Apr 2018 07:00

RNS Number : 0009M
Alexander Mining PLC
25 April 2018
 

25 April 2018

Alexander Mining plc

("Alexander" or the "Company")

Research and Development Update

 

Alexander is pleased to provide an update on its research and development activities.

Lithium - research and development joint venture

Alexander is pleased to announce an extension and expansion of the Lithium Ore Processing Joint Venture ("JV") has been agreed with Dr. Nicholas Welham. Dr. Welham has been Alexander's Principal Technological Consultant for around 10 years and is a principal inventor of the Company's proprietary AmmLeach® and HyperLeach™ technologies.

Dr. Welham has recently identified some potential opportunities which are not presently captured within the JV, which currently covers the testing and development of a potential heap leaching process for hard rock lithium ores. As a consequence, the JV will now additionally investigate reducing the complexity and cost of the conversion process from mineral to battery grade lithium carbonate and/or hydroxide. There is continued and increasing interest from the mining industry in hard rock sources of lithium, including in some regions not generally known to be lithium rich, to which the potential heap leaching processing technology could be applicable.

Preliminary discussions with potential partners in the UK, rest of Europe and Australia are underway with a view to increasing the funding available for development stages subsequent to the initial 'proof of concept' stage from both private and governmental sources. A further announcement will be made when new arrangements are in place.

Given these new developments, the timing for reporting the initial JV test results will be revised and reported upon in due course.

HyperLeach®

Work on the HyperLeach® trials of a nickel-cobalt flotation tailings sample will be undertaken in the next few weeks. The successful completion of the project would allow Alexander to seek significant funding to bring into rapid production a small scale, low cost operation to produce battery grade nickel sulphate and cobalt sulphate for sale into the battery market.

A second HyperLeach® trial is planned to run for the next few months to examine the heap leaching of low grade copper sulphide ore. Chalcopyrite bearing copper ores are notoriously slow to leach under atmospheric conditions. HyperLeach® has been shown to leach ground chalcopyrite ores and flotation concentrates very rapidly, but the behaviour in a heap leach scenario has not been explored. The decreasing head grade worldwide of chalcopyrite ores makes it increasingly difficult to use flotation and smelting to economically produce copper metal thereby opening up such ores to lower cost options, such as heap leaching. 

This announcement contains inside information for the purposes of Article 7 of EU Regulation 596/2014. 

 

ENDS

For further information, please contact:

 

Martin Rosser

Chief Executive

Mobile: +44 (0) 7770 865 341

 

 

Alan Clegg

Non-Executive Chairman

Mobile: +90 543 533 0665

 

 

Alexander Mining plc

Tel: +44 (0) 20 7078 9566

Email: mail@alexandermining.com

Website: www.alexandermining.com

 

 

Northland Capital Partners Limited 

Matthew Johnson / Dugald J Carlean

(Corporate Finance)

John Howes

(Corporate Broking)

Tel: +44 (0) 20 3861 6625

 

Turner Pope Investments (TPI) Ltd

Andy Thacker

Tel: +44 (0) 20 3621 4120

 

 

This information is provided by RNS
The company news service from the London Stock Exchange
 
END
 
 
RESUSOBRWRASUAR
Date   Source Headline
1st Jun 20267:00 amRNSPublication of AR, Notice of AGM and Board Update
18th May 20267:00 amRNSDirectorate change
13th May 20267:00 amRNSBoard changes
30th Apr 20267:00 amRNSFinal Results for the Year Ended 31 December 2025
16th Apr 20267:00 amRNSQ1 Trading Update, Revenue Recognition & Outlook
4th Mar 20267:00 amRNS-RContract wins
23rd Feb 20267:00 amRNSLoan Agreement
23rd Jan 20267:00 amRNSTrading Update
22nd Jan 20267:00 amRNSLaunch of new funding solution and first contract
19th Jan 20267:00 amRNSAppointment of Non-Executive Director
15th Dec 20257:00 amRNSFY Trading Update
27th Nov 20257:00 amRNSDirectorate change
17th Nov 20253:20 pmRNSAward of Options
12th Nov 20254:38 pmRNSSolar Agreement, Loan Agreement, Grant of Warrants
29th Oct 202511:39 amRNSHolding(s) in Company
27th Oct 20257:00 amRNS-RLargest EV Charging Project to Date with NHS
23rd Oct 20252:10 pmRNSHolding(s) in Company
20th Oct 20251:28 pmRNSHolding(s) in Company
1st Sep 20257:00 amRNSPreferred supplier for major solar contract
22nd Aug 20253:04 pmRNSHolding(s) in Company
21st Aug 20253:09 pmRNSHolding(s) in Company
19th Aug 202510:50 amRNSHolding(s) in Company
7th Aug 202512:13 pmRNSHolding(s) in Company
31st Jul 20255:17 pmRNSResult of AGM
22nd Jul 20257:00 amRNSUnaudited HY Results - Six Months Ended 30.06.25
3rd Jul 202510:46 amRNSNotice of AGM
30th Jun 20257:00 amRNSNotice of Results
13th Jun 20259:30 amRNSNotice of FY Results and Investor Presentation
3rd Jun 20259:25 amRNSHolding(s) in Company
20th May 202511:10 amRNSHolding(s) in Company
16th May 20257:00 amRNS£100m Partnership with Redaptive
7th Apr 20257:00 amRNS-RFramework win
26th Mar 20257:00 amRNS-RLaunch of SolarLife
24th Mar 20257:00 amRNS-RContracts wins and appointment to a Framework
11th Mar 20257:00 amRNS-RContract Wins
12th Feb 202511:17 amRNSHolding(s) in Company
3rd Feb 20257:00 amRNS-RInvestor Meet Company Presentation
30th Jan 20257:00 amRNSTrading update
19th Dec 20241:45 pmRNSAward of Options and PDMR Transactions
28th Nov 20247:00 amRNS-RLED Conversion Contract in Further Education
15th Oct 202410:45 amRNSHolding(s) in Company
1st Oct 20247:00 amRNSDirector appointment - additional information
30th Sep 20247:00 amRNSResults for the six months ended 30 June 2024
6th Sep 20247:00 amRNSHolding(s) in Company
8th Aug 20247:00 amRNSInvestor Presentations
26th Jul 20247:00 amRNSH1 24 Trading Update
28th Jun 20243:03 pmRNSResult of AGM
13th Jun 20247:00 amRNSNotice of General Meeting
30th Apr 20247:01 amRNSFinal Results for the 18 months ended 31 Dec 2023
22nd Apr 20247:00 amRNSMajor Contract Win with Spire Healthcare

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.